Drug supply agreements with accession option
Arzneimittelverträge mit Beitrittsoption
Germany · Wuppertal · how to bid here →
Your path to submission
- Deadline: 1 August at 00:00 — 683 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (81 awards, most recently August 2026) — the next award is due around October 2026 by that rhythm. The last award went to Aristo Pharma GmbH.n = 81
- The median procedure drew 6 bids (277 procedures with a bid count); 17% ended with a single bidder. Sector: median 2 bids.n = 277
- 50% of this buyer's awards went to companies that had already won here before (277 awards since 2024, spread over 134 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 277 awards since 2024
- < 1% of the bids received came from other countries (149 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 149
- From notice to award takes a median 137 days here (89 procedures). Sector: 90 days.n = 89
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 257 contracts went to foreign companies over the last 3 years (of 21,997 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 11 (from 81 awards).
What the buyer is looking for
The summary in English is being prepared. The official description below is in the original language (DE).
Show original description (DE)
Die vorliegende Bekanntmachung betrifft nicht die Vergabe eines öffentlichen Auftrags im Sinne der Vergabekoordinierungsrichtlinie (2014/24/EU) bzw. des Kartellvergaberechts. Im Interesse einer möglichst breit angelegten Information der interessierten pharmazeutischen Unternehmer erfolgt diese Bekanntmachung im Supplement zum Amtsblatt der Europäischen Union. Die im Rahmen des vorliegenden Bekanntmachungstextes verwendete Verfahrensbezeichnung "Offenes Verfahren" (Ziffer IV.1.1) ist den Vorgaben des Bekanntmachungsformulars geschuldet. Hiermit sowie mit der Nutzung des Mediums "TED" ist keinerlei Unterwerfung unter vergaberechtliche Regelungen verbunden, deren Geltung kraft Gesetzes bzw. Vergabeordnungen nicht verpflichtend vorgegeben ist. Es handelt sich um einen Rahmenvertrag mit Beitrittsoption, der sich auf diverse Wirkstoffe bezieht.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in DEU, DEU, DEU.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| AMAROX PHARMA GmbH · Haar | 6 | 2025–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 6 | 2025–2026 |
| Basics GmbH · Leverkusen | 5 | 2026 |
| T-Systems International GmbH · Düsseldorf | 5 | 2024–2025 |
| Werbeartikel Muesch e.K. · Troisdorf | 5 | 2024–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.